Form 8-K - Current report:
SEC Accession No. 0001437749-24-001909
Filing Date
2024-01-23
Accepted
2024-01-23 07:37:15
Documents
13
Period of Report
2024-01-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20240112_8k.htm   iXBRL 8-K 32931
  Complete submission text file 0001437749-24-001909.txt   169593

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240123.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240123_def.xml EX-101.DEF 11807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240123_lab.xml EX-101.LAB 15858
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240123_pre.xml EX-101.PRE 12022
7 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240112_8k_htm.xml XML 2659
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 24550487
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)